Initial discovery conversation, about 5 to 7 minutes
First discovery call with Northstar Biotherapeutics
A first conversation with a sceptical Director of Clinical Quality who already receives risk reports from her CROs.
Your job is to understand before you recommend.
Your role
You're a member of the commercial team at TrialSignal, a clinical-trial quality and risk-oversight platform that helps sponsors bring information from multiple study partners and systems into a more consistent oversight view.
Meeting context
Maya has agreed to a short introductory conversation. She isn't convinced Northstar needs another technology platform. This isn't a product presentation, and it isn't the moment to close a sale.
MP
Dr Maya Patel
Director of Clinical Quality, Northstar Biotherapeutics
Mid-sized biotechnology company with several Phase II and Phase III studies
Works with multiple CROs and specialist partners
Responsible for confidence in study quality and sponsor oversight
In this conversation, aim to
Establish Maya's context
Understand the current oversight process
Explore friction and inconsistency
Identify operational and business consequences
Clarify stakeholders, priorities and urgency
Respond constructively to resistance
Summarise the need accurately
Agree an appropriate next step
You won't get through all eight by working down the list. Maya responds to how you listen, not to which questions you ask.
All organisations, people, studies and products are fictional. Please don't enter personal, patient or confidential information. Maya's replies and your coaching are generated by AI.
Conversation with Dr Maya Patel
Maya has wrapped up the meeting.
Preparing your coaching
Your full conversation is being assessed against the rubric. This usually takes 20 to 40 seconds.